Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Prevention of Cerebral Vasospasm in SAH
NCT01091870Phase 2Withdrawn
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in cerebral vasospasm, sponsored by Hospital de Clínicas de Porto Alegre. Planned start Mar 2010; status: withdrawn.
02
Drugs
sildenafil
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT01091870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091870.